Trends and Health Care Outcomes Among Living Liver Donors: Are We Ready to Expand the Donor Pool With Living Liver Donations?
Journal
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
11
06
2021
accepted:
15
06
2021
pubmed:
3
7
2021
medline:
3
11
2021
entrez:
2
7
2021
Statut:
ppublish
Résumé
We studied the trends and various outcomes, including the readmission rates, health care utilization, and complications among living liver donors (LLDs) in the United States. We queried the National Database for data from 2010 to 2017 for all LLDs. The primary outcomes were 30-day and 90-day readmission rates. The secondary outcomes included health care use (length of stay [LOS], cost of care), index admission, and calendar-year mortality. Logistic regression models were fit for various outcomes. A total of 1316 LLDs underwent hepatectomy during the study period. The median donor age was 35.0 years (interquartile range, 27.4-43.6), and donors were predominantly women (54.2%). The trend of LLD surgeries remained stable at large medical centers (85.3%). The 30-day and 90-day readmission rates were low at 5% and 5.9%, respectively. Older age (50 years and older; 8%; confidence interval [CI], 0.6%-15.9%; P = 0.03) and hepatectomy at small to medium-sized hospitals were associated with increased index LOS (13.4%; 95% CI, 3.1%-24.7%; P = 0.01). Moreover, older age of donor (-11.3%; 95% CI, -20.3% to -1.4%; P = 0.03), Elixhauser score ≥3 (17%; 95% CI, 1.2%-35.3%; P = 0.03), and Medicaid insurance (24.5%; 95% CI, 1.2%-53.1%; P = 0.04) were also associated with increased cost. The overall rate of any complications during index admission was 42.8%. Male sex (odds ratio [OR], 1.63; 95% CI, 1.19-2.23) was an independent predictor of post-LLD complications. There was no index admission or calendar-year mortality reported during the study period. This is the largest national report of LLDs to date, showing that the trend of LLD surgeries is stable in the United States. With established safety, fewer complications, and less health care utilization, LLDs can be a potential source of continuation of liver transplantation in the context of changing liver allocation policies in the United States.
Identifiants
pubmed: 34213813
doi: 10.1002/lt.26223
pii: 01445473-202111000-00014
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1603-1612Informations de copyright
Copyright © 2021 by the American Association for the Study of Liver Diseases.
Références
Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, et al. the A2ALL Study Group . Recipient morbidity after living and deceased donor liver transplantation. A2ALL Retrospective Cohort Study. Am J Transplant. 2008;8:2569–79.
Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, et al.; A2ALL Study Group . Donor morbidity after living donation for liver transplantation. Gastroenterology 2008;135:468–476.
Olthoff KM, Abecassis MM, Emond JC, Kam I, Merion RM, Gillespie BW, et al.; Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study Group . Outcomes of adult living donor liver transplantation: comparison of the Adult‐to‐adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl 2011;17:789–797.
Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, et al.; A2ALL Study Group . Complications of living donor hepatic lobectomy—a comprehensive report. Am J Transplant 2012;12:1208–1217.
Abu‐Gazala S, Olthoff KM. Status of adult living donor liver transplantation in the United States: results from the Adult‐To‐Adult Living Donor Liver Transplantation Cohort Study. Gastroenterol Clin N Am 2018;47:297–311.
Abu‐Gazala S, Olthoff KM. Current status of living donor liver transplantation in the United States. Annual Rev Med 2019;70:225–238.
Enkhbold C, Morine Y, Utsunomiya T, Imura S, Ikemoto T, Arakawa Y, et al. Dysfunction of liver regeneration in aged liver after partial hepatectomy. J Gastroenterol Hepatol 2015;30:1217–1224.
Ikegami T, Nishizaki T, Yanaga K, Shimada M, Kishikawa K, Nomoto K, et al. The impact of donor age on living donor liver transplantation. Transplantation 2000;70:1703–1707.
Kubota T, Hata K, Sozu T, Ueda Y, Hirao H, Okamura Y, et al. impact of donor age on recipient survival in adult to adult living‐donor liver transplantation. Ann Surg 2018;267:1126–1133.
Patel S, Orloff M, Tsoulfas G, Kashyap R, Jain A, Bozorgzadeh A, Abt P. Living‐donor liver transplantation in the United States: identifying donors at risk for perioperative complications. Am J Transplant 2007;7:2344–2349.